Close Menu

23andMe

The company beat the consensus Wall Street estimate on the top line but narrowly missed it on the bottom line. 

The move raises questions about what precisely is an LDT outside of FDA jurisdiction and heightens concerns that poorly validated tests will enter the market and endanger public health.

The firm can now tell customers if their genotypes may impact their response to clopidogrel and citalopram without the need for confirmatory testing.

The next iteration of Ancestry's Health experience seeks to provide customers with actionable information about certain commonly inherited health conditions.

Using historical records and genetic data from consented 23andMe customers and others, researchers provided new insights about slavery in the Americas.

In the study, called Coronagenes, the team aims to identify genes that influence the risk of developing COVID-19 and affect disease severity.

Stat News offers ways consumer genetic testing companies could address racial disparities.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

Data collected from volunteers will be used in a genome-wide association study to better understand COVID-19.

The Helsinki-based firm is making its panel available for free to people who already have been genotyped by consumer genomics services or biobanks.

Pages

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.